Tetsuya Furukawa

975 total citations
35 papers, 714 citations indexed

About

Tetsuya Furukawa is a scholar working on Epidemiology, Rheumatology and Nephrology. According to data from OpenAlex, Tetsuya Furukawa has authored 35 papers receiving a total of 714 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 7 papers in Rheumatology and 6 papers in Nephrology. Recurrent topics in Tetsuya Furukawa's work include Metabolism and Genetic Disorders (3 papers), Traumatic Brain Injury Research (3 papers) and Dialysis and Renal Disease Management (3 papers). Tetsuya Furukawa is often cited by papers focused on Metabolism and Genetic Disorders (3 papers), Traumatic Brain Injury Research (3 papers) and Dialysis and Renal Disease Management (3 papers). Tetsuya Furukawa collaborates with scholars based in Japan, United States and China. Tetsuya Furukawa's co-authors include Shintaro Kikuchi, Michihiko Ike, Kazunari Sei, Tadashi Toyama, Kazuhiro Mori, Daisuke Inoue, Masanori Abe, Takashi Maruyama, Hiroyuki Takashima and Nicolas Schweighofer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Water Research.

In The Last Decade

Tetsuya Furukawa

31 papers receiving 697 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tetsuya Furukawa Japan	13	139	119	116	80	80	35	714
Jie Ning China	19	233 1.7×	33 0.3×	86 0.7×	22 0.3×	83 1.0×	49	855
Jennifer L. Sloan United States	25	660 4.7×	32 0.3×	63 0.5×	119 1.5×	58 0.7×	57	1.5k
Yuji Hataya Japan	11	117 0.8×	105 0.9×	287 2.5×	14 0.2×	88 1.1×	26	1.3k
J Nishikawa Japan	11	235 1.7×	52 0.4×	32 0.3×	19 0.2×	35 0.4×	48	662
Shan Gao China	22	380 2.7×	13 0.1×	109 0.9×	25 0.3×	259 3.2×	112	1.3k
Johannes K. Ehinger Sweden	14	330 2.4×	32 0.3×	28 0.2×	91 1.1×	59 0.7×	29	657
Wanwei Li China	13	147 1.1×	69 0.6×	13 0.1×	95 1.2×	81 1.0×	31	641
Mafalda Cacciottolo United States	17	480 3.5×	99 0.8×	32 0.3×	58 0.7×	137 1.7×	29	1.4k
Luyao Ma China	14	230 1.7×	53 0.4×	24 0.2×	13 0.2×	49 0.6×	74	703
I. Hutton United Kingdom	24	97 0.7×	48 0.4×	136 1.2×	28 0.3×	128 1.6×	90	1.8k

Countries citing papers authored by Tetsuya Furukawa

Since Specialization

Citations

This map shows the geographic impact of Tetsuya Furukawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsuya Furukawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsuya Furukawa more than expected).

Fields of papers citing papers by Tetsuya Furukawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsuya Furukawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsuya Furukawa. The network helps show where Tetsuya Furukawa may publish in the future.

Co-authorship network of co-authors of Tetsuya Furukawa

This figure shows the co-authorship network connecting the top 25 collaborators of Tetsuya Furukawa. A scholar is included among the top collaborators of Tetsuya Furukawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tetsuya Furukawa. Tetsuya Furukawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hashimoto, Teppei, Takahiro Yoshikawa, Tetsuya Furukawa, et al.. (2025). Nocturnal baricitinib administration leads to rapid drug responses in rheumatoid arthritis: a multicenter non-randomized controlled study. Arthritis Research & Therapy. 27(1). 91–91.

Azuma, Naoto, et al.. (2024). Autonomic disorder in systemic lupus erythematosus: autoimmune autonomic ganglionopathy. Immunological Medicine. 47(4). 285–288. 1 indexed citations

Hashimoto, Hironobu, et al.. (2023). Efficacy of Preventive Drug Preparation Errors by Non-Pharmacists Using Personal Digital Assistance and Audit Support Systems. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 49(2). 51–58.

Kawazoe, Hitoshi, Yoshimasa Saito, Hironobu Hashimoto, et al.. (2023). Clinical and biomarker factors affecting survival in patients with platinum-sensitive relapsed ovarian cancer receiving olaparib monotherapy: a multicenter retrospective study. Scientific Reports. 13(1). 11962–11962. 1 indexed citations

Furukawa, Tetsuya, Takahiro Yoshikawa, Teppei Hashimoto, et al.. (2023). Involvement of YKL-40-positive macrophages commonly identified in polymyositis and dermatomyositis in the pathogenesis of myositis: a retrospective study. Immunological Medicine. 47(1). 37–44. 1 indexed citations

Kawazoe, Hitoshi, Keisuke Seto, Yoshimasa Saito, et al.. (2022). Patient-associated risk factors for severe anemia in patients with advanced ovarian or breast cancer receiving olaparib monotherapy: A multicenter retrospective study. Frontiers in Oncology. 12. 898150–898150. 5 indexed citations

Furukawa, Tetsuya, et al.. (2022). TAFRO syndrome with renal biopsy successfully treated with steroids and cyclosporine: a case report. BMC Nephrology. 23(1). 262–262. 4 indexed citations

Hashimoto, Teppei, Shigeharu Ueki, Yosuke Kamide, et al.. (2022). Increased Circulating Cell-Free DNA in Eosinophilic Granulomatosis With Polyangiitis: Implications for Eosinophil Extracellular Traps and Immunothrombosis. Frontiers in Immunology. 12. 801897–801897. 41 indexed citations

Abe, Kentaro, Shintaro Iwata, Eisuke Kobayashi, et al.. (2022). Risk Factors for Hepatic Toxicity of High-dose Methotrexate in Patients With Osteosarcoma. Anticancer Research. 42(2). 1043–1050. 10 indexed citations

10.

Inamoto, Yoshihiro, Jun Aoki, Ayumu Ito, et al.. (2022). Differences in kinetics of tacrolimus concentration after letermovir discontinuation by type of concomitant azole antifungal. International Journal of Hematology. 115(2). 158–162. 6 indexed citations

11.

Maruyama, Takashi, Hiroyuki Takashima, Yoshihiro Nakamura, et al.. (2019). Canagliflozin Improves Erythropoiesis in Diabetes Patients with Anemia of Chronic Kidney Disease. Diabetes Technology & Therapeutics. 21(12). 713–720. 73 indexed citations

12.

Higuchi, Terumi, et al.. (2019). Prevalence of Carnitine Deficiency and Decreased Carnitine Levels in Patients on Hemodialysis. Blood Purification. 47(Suppl. 2). 38–44. 15 indexed citations

13.

Furukawa, Tetsuya, Kiyoshi Matsui, Masayasu Kitano, et al.. (2018). Relationship between YKL-40 and pulmonary arterial hypertension in systemic sclerosis. Modern Rheumatology. 29(3). 476–483. 14 indexed citations

14.

Maruyama, Takashi, Noriaki Maruyama, Terumi Higuchi, et al.. (2018). Efficacy of L-carnitine supplementation for improving lean body mass and physical function in patients on hemodialysis: a randomized controlled trial. European Journal of Clinical Nutrition. 73(2). 293–301. 23 indexed citations

15.

Takashima, Hiroyuki, Yoshinori Yoshida, Tetsuya Furukawa, et al.. (2018). Renoprotective effects of canagliflozin, a sodium glucose cotransporter 2 inhibitor, in type 2 diabetes patients with chronic kidney disease: A randomized open-label prospective trial. Diabetes and Vascular Disease Research. 15(5). 469–472. 42 indexed citations

16.

Tsunoda, Shinichiro, Tetsuya Furukawa, Takahiro Yoshikawa, et al.. (2015). A case of HELLP syndrome at 34w-pregnancy with systemic lupus erythymatosus and antiphospholipid antibody syndrome; Importance of measurement of VW factor. Japanese Journal of Clinical Immunology. 38(2). 121–126. 1 indexed citations

17.

Toyama, Tadashi, Tetsuya Furukawa, Daisuke Inoue, et al.. (2010). Accelerated biodegradation of pyrene and benzo[a]pyrene in the Phragmites australis rhizosphere by bacteria–root exudate interactions. Water Research. 45(4). 1629–1638. 182 indexed citations

18.

Takei, Hiroyuki, Yuichi Komaba, Hiroshi Kitamura, et al.. (2004). Aneurysmal subarachnoid hemorrhage in a patient with Wegener?s granulomatosis. Clinical and Experimental Nephrology. 8(3). 274–278. 21 indexed citations

19.

Furukawa, Tetsuya, Shigeru Hoshino, Shiro Kobayashi, et al.. (2003). The Glutamate AMPA Receptor Antagonist, YM872, Attenuates Cortical Tissue Loss, Regional Cerebral Edema, and Neurological Motor Deficits after Experimental Brain Injury in Rats. Journal of Neurotrauma. 20(3). 269–278. 26 indexed citations

20.

Hoshino, Shigeru, Akira Tamaoka, Masayasu Takahashi, et al.. (1998). Emergence of immunoreactivities for phosphorylated tau and amyloid-β protein in chronic stage of fluid percussion injury in rat brain. Neuroreport. 9(8). 1879–1883. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact